Treatment of women with low-grade squamous intraepithelial lesions on cytologic evidence or biopsy results by board-certified gynecologists

American Journal of Obstetrics and Gynecology

Volumn 188, Issue 3, 2003, Pages 693-698

  Lee, Chris ^a   Mancuso, Victoria ^a   Contant, Tracy ^a   Jackson, Rebecca ^a   Smith McCune, Karen ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Cancer Research Institute   (United States)

Author keywords

Abnormal Papanicolaou test; Bethesda system; Cervical intraepithelial neoplasia; Dysplasia; Human papillomavirus; Mild dysplasia

Indexed keywords

ARTICLE; CERTIFICATION; CLINICAL PRACTICE; COLPOSCOPY; CONDOM; CONDYLOMA; GYNECOLOGY; HEALTH SURVEY; HUMAN; MEDICAL PRACTICE; NORMAL HUMAN; PAPANICOLAOU TEST; PATIENT COUNSELING; PREVALENCE; PRIORITY JOURNAL; SEXUALITY; TUMOR BIOPSY; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX DYSPLASIA; VIRUS TITRATION; WART VIRUS;

EID: 0037341232     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1067/mob.2003.174     Document Type: Article

References (23)

1. Papanicolaou GN, Traut HF. The diagnostic value of vaginal smears in carcinoma of the cervix. Arch Pathol Lab Med 1997; 41:211-24.
2. Eddy D. Screening for cervical cancer. Ann Intern Med 1990;113:214-26.
3. Schiffman MH, Bauer HM, Hoover P, RN, Glass AG, Cadell DM, Rush BB, et al. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst 1993;85:958-64.
4. Kurman R, Henson D, Herbst A, Noller K, Schiffman M. Interim guidelines for management of abnormal cervical cytology. JAMA 1994;271:1866-9.
5. Broder S. The Bethesda system for reporting cervical/vaginal cytologic diagnoses: report of the 1991 Bethesda workshop. JAMA 1992;267:1892.
6. National Cancer Institute Workshop. The Bethesda system for reporting cervical/vaginal cytological diagnoses. JAMA 1989;262:931-4.
7. Ho GY, Bierman R, Beardsley L, Chang CJ, Burk RD. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 1998;338:423-8.
8. Nasiell K, Roger V, Nasiell M. Behavior of mild cervical dysplasia during long-term follow-up. Obstet Gynecol 1986;67:665-9.
9. Nash JD, Burke TW, Hoskins WJ. Biologic course of cervical human papillomavirus infection. Obstet Gynecol 1987;69:160-2.
10. Montz FJ, Monk BJ, Powler JM, Nguyen L. Natural history of the minimally abnormal Papanicolaou smear. Obstet Gynecol 1992;80:385-8.
11. ALTS Group. Human papillomavirus testing for triage of women with cytologic evidence of low-grade squamous intraepithelial lesions: baseline data from a randomized trial. J Natl Cancer Inst 2000;92:397-402.
12. Davey DD, Woodhouse S, Styer P, Stastny J, Mody D. Atypical epithelial cells and specimen adequacy: current laboratory practices of participants in the college of American pathologists interlaboratory comparison program in cervicovaginal cytology. Arch Pathol Lab Med 2000;124:203-11.
13. Ostor AG. Natural history of cervical intraepithelial neoplasia: a critical review. Int J Gynecol Pathol 1993;12:186-92.
14. American College of Obstetricians and Gynecologists. Cervical cytology: evaluation and management of abnormalities. Washington (DC): American College of Obstetricians and Gynecologists; 1993. Technical bulletin.
15. Partridge E. NCCN practice guidelines for cervical cancer screening. Oncology 1999;13:540-74.
16. Wright TC Jr, Cox JT, Massad LS, Twiggs LB, Wilkinson EJ. 2001 Consensus guidelines for the management of women with cervical cytological abnormalities. JAMA 2002;287:2120-9.
17. Gordon P, Hatch K. Survey of colposcopy practices by obstetricians/gynecologists. J Reprod Med 1992;37:861-3.
18. Curtis P, Morrell D, Hendrix S, Mintzer M, Resnick J, Qaquish B. Recall and treatment decisions of primary care providers in response to Pap smear reports. Am J Prev Med 1997;13:427-31.
19. Ferris DG, Miller MD, Wagner P, Walaitis E, Lawler FH. Clinical decision-making following abnormal Papanicolaou smear reports. Fam Pract Res J 1993;13:343-53.
20. Smith-McCune K, Mancuso V, Contant T, Jackson R. Management of women with atypical Papanicolaou tests of undetermined significance by board-certified gynecologists: discrepancies with published guidelines. Am J Obstet Gynecol 2001;185:551-6.
21. Solomon D, Davey D, Kurman R, Moriarty A, O'Connor D, Prey M, et al. The 2001 Bethesda system: terminology for reporting results of cervical cytology. JAMA 2002;287:2114-9.
22. Curtis P, Morrell D, Hendrix S, Mintzer M, Resnick JC, Qaqish BF. Recall and treatment decisions of primary care providers in response to Pap smear reports. Am J Prev Med 1997;13:427-31.
23. Centers for Disease Control and Prevention. 1998 Guidelines for treatment of sexually transmitted diseases. MMWR Recomm Rep 1998;47.